On September 30, 2026, JPMorgan Chase & Co. disposed of 1.15 million H shares of PHARMARON (03759) off‑exchange at an average of HKD 31.3497 per share, involving about HKD 35.93 million, as a cash consideration transaction. This was an off‑exchange trade, not matched on the SEHK open market and therefore not a direct secondary‑market dealing. Additionally, JPMorgan Chase & Co. reduced its short position through the expiry or cancellation of equity derivatives, an off‑exchange derivative adjustment rather than a direct dealing in the underlying shares.

Prior to the disposal, JPMorgan Chase & Co.'s long position in PHARMARON was 55.14 million shares, representing 15.31%; following the disposal, the holding changed to 54.00 million shares, with the long position ratio falling to 14.99%. The short position decreased from 14.67 million shares (4.07%) to 13.84 million shares (3.84%).